Brandes Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71M Buy
77,925
+18,485
+31% +$1.62M 0.05% 138
2026
Q1
$5.37M Buy
59,440
+10,577
+22% +$971K 0.04% 138
2025
Q4
$4.39M Buy
48,863
+33,368
+215% +$3.16M 0.03% 145
2025
Q3
$1.53M Buy
15,495
+2,730
+21% +$271K 0.01% 163
2025
Q2
$1.16M Buy
12,765
+2,704
+27% +$261K 0.01% 163
2025
Q1
$1.14M Buy
10,061
+1,943
+24% +$208K 0.01% 154
2024
Q4
$858K Buy
8,118
+2,268
+39% +$243K 0.01% 167
2024
Q3
$632K Buy
5,850
+1,351
+30% +$147K 0.01% 173
2024
Q2
$488K Buy
4,499
+1,258
+39% +$148K 0.01% 175
2024
Q1
$428K Buy
3,241
+1,485
+85% +$185K 0.01% 168
2023
Q4
$214K Buy
+1,756
New +$196K ﹤0.01% 183

Other funds holding ZBH

Brandes Investment Partners's ZBH Position: Q2 2026 in Review

Brandes Investment Partners increased its Zimmer Biomet (ZBH) stake by 31% in Q2 2026, buying an estimated $1.62M and bringing the position to 77,925 shares worth $6.71M. The position accounts for 0.05% of the portfolio, ranked #138.

Brandes Investment Partners first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Brandes Investment Partners held 77,925 shares of Zimmer Biomet worth $6.71M as of Q2 2026.
  • Brandes Investment Partners bought 18,485 Zimmer Biomet shares in Q2 2026, an estimated $1.62M.
  • Zimmer Biomet made up 0.05% of Brandes Investment Partners's portfolio in Q2 2026, its #138 holding.
  • Brandes Investment Partners first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Brandes Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.